Alps Advisors Inc Viking Therapeutics, Inc. Transaction History

Alps Advisors Inc

  • $14.1 Billion
  • Q1 2024

A detailed history of Alps Advisors Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 74,007 shares of VKTX stock, worth $3.92 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
74,007
Previous 66,377 11.49%
Holding current value
$3.92 Million
Previous $1.24 Million 391.34%
% of portfolio
0.04%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$17.4 - $94.5 $132,762 - $721,035
7,630 Added 11.49%
74,007 $6.07 Million
Q4 2023

Feb 14, 2024
SELL
$9.24 - $19.64 $68,634 - $145,885
-7,428 Reduced 10.06%
66,377 $1.24 Million
Q3 2023

Nov 14, 2023
BUY
$10.92 - $16.0 $4,564 - $6,688
418 Added 0.57%
73,805 $817,000
Q2 2023

Aug 14, 2023
BUY
$14.84 - $24.79 $321,567 - $537,174
21,669 Added 41.9%
73,387 $1.19 Million
Q1 2023

May 10, 2023
SELL
$8.08 - $17.33 $2,626 - $5,632
-325 Reduced 0.62%
51,718 $861,000
Q4 2022

Feb 14, 2023
BUY
$2.72 - $9.4 $141,556 - $489,204
52,043 New
52,043 $489,000
Q2 2022

Aug 11, 2022
SELL
$2.11 - $3.15 $169,939 - $253,701
-80,540 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$3.0 - $4.88 $29,997 - $48,795
-9,999 Reduced 11.04%
80,540 $242,000
Q4 2021

Feb 09, 2022
SELL
$4.6 - $6.72 $24,361 - $35,589
-5,296 Reduced 5.53%
90,539 $416,000
Q3 2021

Nov 15, 2021
SELL
$5.58 - $7.04 $39,227 - $49,491
-7,030 Reduced 6.83%
95,835 $602,000
Q2 2021

Aug 11, 2021
SELL
$5.19 - $6.73 $151,096 - $195,930
-29,113 Reduced 22.06%
102,865 $616,000
Q1 2021

May 07, 2021
BUY
$5.74 - $9.67 $2,692 - $4,535
469 Added 0.36%
131,978 $835,000
Q4 2020

Feb 03, 2021
BUY
$5.3 - $6.71 $205,210 - $259,804
38,719 Added 41.73%
131,509 $740,000
Q3 2020

Nov 04, 2020
SELL
$5.73 - $8.11 $35,738 - $50,582
-6,237 Reduced 6.3%
92,790 $540,000
Q2 2020

Aug 05, 2020
SELL
$4.35 - $8.08 $140,726 - $261,396
-32,351 Reduced 24.62%
99,027 $714,000
Q1 2020

May 06, 2020
SELL
$3.45 - $7.95 $52,860 - $121,809
-15,322 Reduced 10.44%
131,378 $615,000
Q4 2019

Feb 07, 2020
BUY
$6.38 - $8.73 $17,104 - $23,405
2,681 Added 1.86%
146,700 $1.18 Million
Q3 2019

Nov 04, 2019
SELL
$6.55 - $8.6 $44,481 - $58,402
-6,791 Reduced 4.5%
144,019 $991,000
Q2 2019

Aug 07, 2019
SELL
$7.67 - $10.63 $167,152 - $231,659
-21,793 Reduced 12.63%
150,810 $1.25 Million
Q1 2019

May 01, 2019
BUY
$7.58 - $9.94 $56,531 - $74,132
7,458 Added 4.52%
172,603 $1.72 Million
Q4 2018

Feb 04, 2019
BUY
$7.16 - $16.21 $1.18 Million - $2.68 Million
165,145 New
165,145 $1.26 Million

Others Institutions Holding VKTX

# of Institutions
426
Shares Held
63.1M
Call Options Held
7.39M
Put Options Held
5.13M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.07B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email